Psoriatic Arthritis

Apremilast Monotherapy Effective for DMARD-Naive Psoriatic Arthritis

Apremilast Monotherapy Effective for DMARD-Naive Psoriatic Arthritis

By

The PALACE 4 trial found that apremilast monotherapy improved symptoms and was generally well-tolerated in DMARD-naive psoriatic arthritis.

Synovitis Detected by Ultrasound in Psoriatic Arthritis in Remission

Synovitis Detected by Ultrasound in Psoriatic Arthritis in Remission

By

Underlying synovitis and enthesitis may go undetected in clinical findings, but can be detected by power Doppler ultrasounds.

Psoriatic Arthritis Improved With Etanercept Therapy

Psoriatic Arthritis Improved With Etanercept Therapy

By

Etanercept therapy reduces clinical markers of disease activity in patients with psoriatic arthritis while stabilizing cardiovascular disease risk factors over a period of 5 years.

A New Biomarker for Disease Activity in Psoriatic Arthritis?

A New Biomarker for Disease Activity in Psoriatic Arthritis?

By

Serum amyloid A levels were found to significantly correlate with C-reactive protein levels in psoriatic arthritis.

Treatment-Resistant Psoriatic Arthritis Improved by Ixekizumab

Treatment-Resistant Psoriatic Arthritis Improved by Ixekizumab

Ixekizumab benefits patients with treatment-resistant psoriatic arthritis when administered over a 2- or 4-week period.

Updated Psoriatic Arthritis Outcome Measures Offer Greater Inclusion of Patient Concerns

Updated Psoriatic Arthritis Outcome Measures Offer Greater Inclusion of Patient Concerns

Outcome measurement tools for psoriatic arthritis have been updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.

Psoriatic Arthritis Risk Increased by Depression Among Patients With Psoriasis

Psoriatic Arthritis Risk Increased by Depression Among Patients With Psoriasis

By

Researchers have demonstrated that depression is a significant risk factor for progression from psoriasis to psoriatic arthritis.

Developing Biomarkers for Inflammatory Arthritis

Developing Biomarkers for Inflammatory Arthritis

By

Urinary proteomics may help identify biomarkers that can distinguish between different types of inflammatory arthritis.

Fatigue May Predict Depression, Joint Involvement in Psoriatic Disease

Fatigue May Predict Depression, Joint Involvement in Psoriatic Disease

There were higher levels of fatigue in psoriatic arthritis vs psoriasis, and fatigue scores were linked to depression.

Bridging Gaps in Patient Access to Rheumatologists With Telemedicine

Bridging Gaps in Patient Access to Rheumatologists With Telemedicine

By

Telerheumatology can improve healthcare access, patient outcomes, and costs

Rheumatologists and Dermatologists Need to Work Together to Treat Psoriatic Arthritis

Rheumatologists and Dermatologists Need to Work Together to Treat Psoriatic Arthritis

By

Dermatologists are in a key position to screen for psoriatic arthritis (PsA), as the overlapping and variable symptoms of the disease require multidisciplinary care.

Sign Up for Free e-Newsletters